Back to Search
Start Over
Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect
- Source :
- Nanotechnology Reviews, Vol 11, Iss 1, Pp 204-219 (2021)
- Publication Year :
- 2021
- Publisher :
- De Gruyter, 2021.
-
Abstract
- The ανβ3 integrin antagonistic ligands, i.e., drugs as nano-architectural design-based nanomedicine, especially for cancer chemotherapy, are discussed.
Details
- Language :
- English
- ISSN :
- 21919097
- Volume :
- 11
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Nanotechnology Reviews
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b20609f93aed49fba189d59db5a0f705
- Document Type :
- article
- Full Text :
- https://doi.org/10.1515/ntrev-2022-0020